We are live on
!
Find out more
SCM
Sio Capital Management Portfolio holdings
AUM
$694M
1-Year Est. Return
79.73%
This Fund
S&P 500
This Quarter
Est. Return
+0.02%
1 Year Est. Return
+79.73%
3 Year Est. Return
+576.62%
5 Year Est. Return
+422.76%
10 Year Est. Return
+2,506.65%
AUM
$694M
AUM Growth
+$90.7M
(+15%)
Cap. Flow
+$121M
Cap. Flow
% of AUM
17.46%
Top 10 Holdings %
Top 10 Hldgs %
45.36%
Holding
89
New
20
Increased
24
Reduced
16
Closed
12
Top Buys
| 1 |
Cencora
COR
|
+$29.7M |
| 2 |
WAY
Waystar Holding Corp
WAY
|
+$27.3M |
| 3 |
Corcept Therapeutics
CORT
|
+$25.2M |
| 4 |
Icon
ICLR
|
+$24.5M |
| 5 |
Maximus
MMS
|
+$21.8M |
Top Sells
| 1 |
Cigna
CI
|
+$47.4M |
| 2 |
Sanofi
SNY
|
+$34.1M |
| 3 |
Celcuity
CELC
|
+$30.9M |
| 4 |
Zimmer Biomet
ZBH
|
+$29.6M |
| 5 |
Kenvue
KVUE
|
+$25.3M |
Sector Composition
| 1 | Healthcare | 92.9% |
| 2 | Industrials | 7.1% |
| 3 | Consumer Staples | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
76
Cigna
CI
$80.2B
| – | – |
-172,203
| Closed | -$47.4M |
|
77
Centene
CNC
$33.9B
| – | – |
-274,350
| Closed | -$11.2M |
|
78
Charles River Laboratories
CRL
$11.1B
| – | – |
-54,985
| Closed | -$11M |
|
79
Elicio Therapeutics
ELTX
$81.7M
| – | – |
0
| – | – |
|
80
Fulcrum Therapeutics
FULC
$239M
| – | – |
-382,000
| Closed | -$4.32M |
|
81
IDEAYA Biosciences
IDYA
$3.53B
| – | – |
-75,730
| Closed | -$2.62M |
|
|
82
Kenvue
KVUE
$36B
| – | – |
-1,465,442
| Closed | -$25.3M |
|
83
McKesson
MCK
$94.1B
| – | – |
-6,400
| Closed | -$5.25M |
|
84
NextCure
NXTC
$26.8M
| – | – |
-10,940
| Closed | -$155K |
|
85
Oscar Health
OSCR
$9.37B
| – | – |
0
| – | – |
|
86
Outlook Therapeutics
OTLK
$257M
| – | – |
0
| – | – |
|
87
Rhythm Pharmaceuticals
RYTM
$7.54B
| – | – |
0
| – | – |
|
|
VTYX
88
DELISTED
Ventyx Biosciences
VTYX
| – | – |
-387,751
| Closed | -$3.5M |
|
89
BrightSpring Health Services
BTSG
$13.7B
| – | – |
-308,010
| Closed | -$11.5M |
|
Similar funds
IIC
MCM
CGIC
HA
BBPWM
M
HG
CA